A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome
Completed · Phase 3 · Has a placebo group
Conditions studied: Sjogrens Disease
In brief
The purpose of this study is to evaluate the efficacy of abatacept compared to placebo in patients with Sjögren's Syndrome.
Key facts
- Study ID
- NCT02915159
- Run by
- Bristol-Myers Squibb
- People needed
- 250
- Starts
- 2016-12-06
- Expected to finish
- 2019-07-23
- Last updated by the study team
- 2020-08-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) score of at least 5
- Positive anti-SS-A/Ro antibody at screening
- meet the 2016 American College of Rheumatology (ACR) / European League Against Rheumatism Classification Criteria for Sjögren's Syndrome (EULAR SS)
You may not qualify if…
- Secondary Sjögrens syndrome
- Active life-threatening or organ-threatening complications of Sjögren's-syndrome
- Other medical condition associated with sicca syndrome
- Other protocol defined inclusion/exclusion criteria could apply
Where it is running
- Riverside Medical Clinic — Riverside, California, United States
- Colorado Arthritis Associates — Lakewood, Colorado, United States
- North Georgia Rheumatology Group — Lawrenceville, Georgia, United States
- Intermountain Research Center Inc. — Boise, Idaho, United States
- Johns Hopkins University — Baltimore, Maryland, United States
- Clinical Pharmacology Study Group — Worcester, Massachusetts, United States
- St. Paul Rheumatology, P.A. — Eagan, Minnesota, United States
- Northwell Health — Great Neck, New York, United States
- Local Institution — Charlotte, North Carolina, United States
- Joint and Muscle Medical Care and Research Institute (JMMCRI) — Charlotte, North Carolina, United States
- Duke Clinical Research Unit, Duke Univ Med Ctr, Duke South — Durham, North Carolina, United States
- Health Research Of Oklahoma — Oklahoma City, Oklahoma, United States
- East Penn Rheumatology — Bethlehem, Pennsylvania, United States
- Altoona Center For Clinical Research — Duncansville, Pennsylvania, United States
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
- West Tennessee Research Institute — Jackson, Tennessee, United States
- Metroplex Clinical Research Center — Dallas, Texas, United States
- Scott Zashin Inc. — Dallas, Texas, United States
- Organizacion Medica De Investigacion S.A. (Omi) — Capital Federal, Buenos Aires, Argentina
- Local Institution — Ciudad Autonoma Beunos Aires, Buenos Aires, Argentina
- Instituto de Asistencia Reumatologica Integral — San Fernando, Buenos Aires, Argentina
- Local Institution — Buenos Aires, Argentina
- Consultorios Medicos Dr. Catalan Pellet — CABA, Argentina
- Instituto Reumatologico Strusberg — Córdoba, Argentina
- St. Jude Hospital Yorba Linda — Fullerton, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.